Top 5 Takeaways Low severity and unusual pattern: The 2021–22 influenza season was characterized by low severity, with activity spanning from October 2021 through mid-June 2022, showcasing two distinct waves

Top 5 Takeaways Emergency Use Authorization Granted: The FDA issued an EUA for the Novavax COVID-19 vaccine on July 13, 2022, for primary immunization in adults aged ≥18 years. ACIP’s

Top 5 Takeaways Significant Global Progress: From 2016 to 2020, global coverage with the third dose of hepatitis B vaccine remained stable while coverage with the hepatitis B birth dose

Top 5 Takeaways Significant Increase in Unsupervised Melatonin Ingestions: Approximately 11,000 emergency department (ED) visits for unsupervised melatonin ingestion by infants and young children occurred during 2019–2022, making up about

Top 5 Takeaways High Effectiveness of Nirsevimab: Nirsevimab demonstrated a 90% effectiveness in preventing RSV-associated hospitalization among infants in their first RSV season. Median Time to Symptom Onset: The median

Top 5 Takeaways Significant Increase in Years of Potential Life Lost (YPLL): YPLL increased from 52,044 years during 2014–2015 to 88,788 years during 2020–2021, indicating a significant rise in premature